Browsing: SCLC

The natural next space for immune checkpoint inhibitors to enter is outback following definitive chemoradiation for limited-stage small cell lung…

Top Line: We are once again reminded of the fact, since firmly established in 1999, that no radiation regimen has…

Headline: Does SRS reduce neurocognitive decline for patients with small cell lung cancer brain metastases? The Study: Although SRS is…

Prophylactic cranial irradiation (PCI) is still the standard for limited stage small cell lung cancer (LS-SCLC), at least until MAVERICK…

Top Line: Do older patients tolerate BID dose escalation for SCLC as well as younger patients? The Study: Back in…

Top Line: Is stereotactic radiosurgery (SRS) a safe option for patients with small cell lung cancer (SCLC) brain metastases? The…

The Graded Prognostic Assessment (GPA) is a tool to help predict survival of patients with brain mets and it’s now…

Top Line: Is there enough data to choose something other than 45 Gy in 30 BID fractions or 66 Gy…

The long-awaited Phase 3 CONVERT trial published this week in Lancet failed to show that once-daily radiation was superior to…